1. Home
  2. PKE vs ENTA Comparison

PKE vs ENTA Comparison

Compare PKE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$32.47

Market Cap

709.3M

Sector

Industrials

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.59

Market Cap

378.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
ENTA
Founded
1954
1995
Country
United States
United States
Employees
125
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
709.3M
378.0M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
PKE
ENTA
Price
$32.47
$13.59
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
202.9K
195.9K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
1.53%
N/A
EPS Growth
93.10
29.93
EPS
0.17
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
N/A
N/A
P/E Ratio
$191.82
N/A
Revenue Growth
N/A
16.48
52 Week Low
$18.19
$7.05
52 Week High
$39.86
$17.15

Technical Indicators

Market Signals
Indicator
PKE
ENTA
Relative Strength Index (RSI) 38.43 50.26
Support Level $31.35 $13.47
Resistance Level $35.94 $13.98
Average True Range (ATR) 1.37 0.67
MACD -0.54 0.05
Stochastic Oscillator 6.58 36.99

Price Performance

Historical Comparison
PKE
ENTA

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: